Cargando…

COVID-19: implications for immunosuppression in kidney disease and transplantation

The coronavirus disease 2019 (COVID-19) pandemic poses important challenges to the care of patients with immune-mediated kidney diseases and to kidney transplant recipients. Here, we discuss the management of immunosuppression for these patients during the pandemic and suggest potential approaches t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kronbichler, Andreas, Gauckler, Philipp, Windpessl, Martin, Il Shin, Jae, Jha, Vivekanand, Rovin, Brad H., Oberbauer, Rainer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224161/ https://www.ncbi.nlm.nih.gov/pubmed/32409782 http://dx.doi.org/10.1038/s41581-020-0305-6

Ejemplares similares

ANCA Status or Clinical Phenotype — What Counts More?
por: Windpessl, Martin, et al.
Publicado: (2021)

COVID-19 vaccines and kidney disease
por: Windpessl, Martin, et al.
Publicado: (2021)

Eosinophilia and Kidney Disease: More than Just an Incidental Finding?
por: Gauckler, Philipp, et al.
Publicado: (2018)

Comorbidities in ANCA-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

The Role of Rituximab in Focal Segmental Glomerulosclerosis–Update From Italy
por: Gauckler, Philipp, et al.
Publicado: (2022)

Diagnostik und Therapie der Membranösen Nephropathie – 2023
por: Säemann, Marcus D., et al.
Publicado: (2023)

Anti-GBM-Nephritis
por: Windpessl, Martin, et al.
Publicado: (2023)

Low-value medical care in the pandemic—is this what the doctor ordered?
por: Bhaumik, Soumyadeep, et al.
Publicado: (2021)

Diagnostik und Therapie der Minimal Change Glomerulopathie beim Erwachsenen – 2023
por: Gauckler, Philipp, et al.
Publicado: (2023)

Allgemeine Empfehlungen für die Behandlung glomerulärer Erkrankungen – 2023
por: Windpessl, Martin, et al.
Publicado: (2023)

Diagnose und Therapie glomerulärer Erkrankungen mit einem membranoproliferativen Läsionsmuster (MPGN) – 2023
por: Rudnicki, Michael, et al.
Publicado: (2023)

The impact of COVID-19 on kidney transplantation
por: Alasfar, Sami, et al.
Publicado: (2020)

Diagnostik und Therapie der Lupusnephritis – 2023
por: Odler, Balazs, et al.
Publicado: (2023)

COVID-19 vaccination in kidney transplant recipients
por: Caillard, Sophie, et al.
Publicado: (2021)

The Risk of Severe Infections Following Rituximab Administration in Patients With Autoimmune Kidney Diseases: Austrian ABCDE Registry Analysis
por: Odler, Balazs, et al.
Publicado: (2021)

Diagnostik und Therapie der Fokal-Segmentalen Glomerulosklerose – 2023
por: Gauckler, Philipp, et al.
Publicado: (2023)

COVID-19 in kidney transplantation-implications for immunosuppression and vaccination
por: Kodali, Lavanya, et al.
Publicado: (2022)

Diagnose und Therapie der Granulomatose mit Polyangiitis und mikroskopische Polyangiitis – 2023: Konsens-Empfehlungen der Österreichischen Gesellschaften für Nephrologie (ÖGN) & Rheumatologie (ÖGR)
por: Odler, Balazs, et al.
Publicado: (2023)

Edema-like symptoms are common in ultra-distance cyclists and driven by overdrinking, use of analgesics and female sex – a study of 919 athletes
por: Gauckler, Philipp, et al.
Publicado: (2021)

Early experience with COVID-19 in kidney transplantation
por: Coates, P. Toby, et al.
Publicado: (2020)

Challenges in operationalising clinical trials in India during the COVID-19 pandemic
por: Bassi, Abhinav, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

SARS-CoV-2 vaccine strategies in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2023)

Kidney Transplantation Is Associated with Catastrophic Out of Pocket Expenditure in India
por: Ramachandran, Raja, et al.
Publicado: (2013)

Immunosuppression in kidney transplantation
por: MUNTEAN, ADRIANA, et al.
Publicado: (2013)

Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
por: Barbhaiya, Medha, et al.
Publicado: (2022)

Kidney Transplantation, Immunosuppression and the Risk of Fracture: Clinical and Economic Implications
por: Kuppachi, Sarat, et al.
Publicado: (2022)

Health-related quality of life outcomes after kidney transplantation
por: Fiebiger, Wolfgang, et al.
Publicado: (2004)

The type I interferon response in COVID-19: implications for treatment
por: Lee, Jeong Seok, et al.
Publicado: (2020)

Kidney International and the COVID-19 infection
por: Rovin, Brad H., et al.
Publicado: (2020)

Assistance and health care provided to adolescents with chronic and immunosuppressive conditions in a tertiary university hospital during the COVID-19 pandemic
por: Lavorato, Sofia S.M., et al.
Publicado: (2021)

Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease
por: Mackintosh, John A, et al.
Publicado: (2021)

COVID-19 and liver transplantation
por: Di Maira, Tommaso, et al.
Publicado: (2020)

Immunologic Changes Implicated in the Pathogenesis of Focal Segmental Glomerulosclerosis
por: Kronbichler, Andreas, et al.
Publicado: (2016)

Novel insights into non‐HLA alloimmunity in kidney transplantation
por: Reindl‐Schwaighofer, Roman, et al.
Publicado: (2019)

Save the kidneys in COVID-19
por: Knight, Philip P., et al.
Publicado: (2020)

Long COVID and kidney disease
por: Yende, Sachin, et al.
Publicado: (2021)

Kidney glomerular filtration rate plasticity after transplantation
por: Denic, Aleksandar, et al.
Publicado: (2021)

When to consider lung transplantation for COVID-19
por: Cypel, Marcelo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gq340epsuoanr10k66fc09oosd